Veness Adam M's Form 4 filing
Dianthus Therapeutics, Inc. (DNTH) · filed Jun 18, 2026
- Accession no.
- 0001778623-26-000005
- Filed
- Jun 18, 2026
- Trade date
- Jun 17, 2026
- Filing delay
- 1 day
- Rule 10b5-1 plan
- Checked
This filing lists 3 non-derivative transactions and 1 derivative transaction. Open-market sales total $2.42M. It was filed 1 day after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Veness Adam MCIK 0001778623 | Officer (SVP, General Counsel and Sec.) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Jun 17, 2026 | Common Stock | MOption exerciseAcquired | +30,000 | $17.88 | +$536,400 | 30,000 | Direct | |
| Jun 17, 2026 | Common Stock | SSaleDisposed | −16,771 | $80.34 | −$1,347,382.14 | 13,229 | Direct | |
| Jun 17, 2026 | Common Stock | SSaleDisposed | −13,229 | $81.38 | −$1,076,576.02 | 0 | Direct |
Derivative securities (Table II)
Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.
| Trade date | Security | Transaction | Underlying shares | Unit price | Value | Held after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Jun 17, 2026 | Common Stock | MOption exerciseDisposed | −30,000 | $0.00 | $0 | 80,000 | Direct |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.